ArticleNucleic acids research2026
PersADE: a database of personalized adverse drug events and their underlying molecular mechanisms.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
14 authors.
Funding
Abstract
As a major burden on global healthcare systems, adverse drug events (ADEs) result in significant morbidity, mortality, and healthcare resource consumption. With the rapid advances in precision medicine, personalized ADEs and their molecular mechanisms are important components of drug repurposing and drug safety improvement. Thus, extensive studies have been conducted to collect valuable information on personalized ADEs, but no database has yet been available to provide such data. In this work, PersADE, a database aiming to provide personalized drug adverse events and their molecular mechanisms, was constructed. It integrated 4 061 772 personalized drug-ADE associations, 31 756 protein-ADE associations, and 108 677 drug-protein interactions, with a particular emphasis on off-target effects. The uniqueness of these data lies in (a) providing demographic characteristics, disease context and drug administration parameters associated with ADEs, enabling stratification of drug-ADE associations; (b) systematically integrating interactions among drugs, human proteins and ADEs, describing the mechanistic insights. Given the growing global focus on precision medicine, PersADE is highly anticipated to significantly impact studies on personalized ADEs and mechanistic explorations by providing researchers and clinicians with evidence-based tools. It is now freely accessible at: https://idrblab.org/PersADE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.